The New York Times recently reported on Canadian studies that suggest that routine monitoring of glucose levels by type 2 diabetic patients using test strips may have limited clinical benefits and may not be an effective use of resources. It will be interesting to see how this plays out in the U.S. with the current emphasis on evidence based medicine and the pressing need to reduce health care costs.